Female pattern hair loss (Androgenetic alopecia)
Conditions
Interventions
5% Minoxidil solution with 1% Melatonin solution,1% Melatonin solution ,5% Minoxidil solution,Placebo
Experimental Drug,Experimental Drug,Active Comparator Drug,Placebo Comparator Drug
Combination group,Melatonin group,Minoxidil group,Placebo group
Sponsors
Faculty of Medicine, Thammasat University (Rungsit campus)
Eligibility
Sex/Gender
Female
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Female pattern hair loss (Androgenetic alopecia), Type II - V of Sinclair scale 2. Healthy status
Exclusion criteria
Exclusion criteria: 1. No topical treatment include minoxidil for AGA within 6 months 2. No topical herb solution for hair growth within 6 months 3. No systemic treatment for AGA within 6 months. For example, oral contraceptive drug, finasteride, dutasteride, spironolactone 4. No history of chemotherapy and radiation within 1 year prior to the clinical trials 5. No topical steroid that apply a scalp at least 14 days within 3 months prior to the trials 6. No pregnancy and breastfeeding status 7. No history of hypersensitivity to melatonin and minoxidil 8. No multiple comorbidities
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Target area hair counts 0,2,4,6 months Leviacam (Trichoscopy) | — |
Secondary
| Measure | Time frame |
|---|---|
| Comb-and-Count 0,2,4,6 months number,Global assessment by photo 0,2,4,6 months 7 scales | — |
Countries
Thailand
Contacts
Public ContactPanlop Chakkavittumrong
Faculty of Medicine
Outcome results
None listed